Because of reduced PRODH gene dosage, it is expected that people with 22q11DS have reduced PRODH enzyme activity and increased Pro levels (Goodman et al. 2000; Magnee et al. 2011; Raux et al. 2007). The gene discussed is PRODH; the disease is 22q11.2 deletion syndrome.